SPBC18H10.05 Antibody

Shipped with Ice Packs
In Stock

Description

Genomic Context and Identification

SPBC18H10.05 is identified in the scientific literature as a gene encoding a WD repeat protein of the Wdr44 family in Schizosaccharomyces pombe . The systematic identifier follows standard S. pombe nomenclature where:

  • SPBC: Indicates a gene located on chromosome II of S. pombe

  • 18H10: Represents the specific cosmid or genomic contig designation

  • 05: Indicates it is the fifth open reading frame on this cosmid

As mentioned in the doctoral dissertation referenced in the search results, SPBC18H10.05 is categorized as a "WD repeat protein Wdr44 family, WD" . This classification provides important insights into the protein's structure and potential functions within the cell.

Functional Implications

Based on knowledge of homologous WD repeat proteins, SPBC18H10.05 likely functions as a scaffolding protein that mediates the assembly of protein complexes. Potential cellular roles may include:

  • Intracellular trafficking and vesicular transport

  • Signal transduction pathway regulation

  • Cytoskeletal organization

  • Cell cycle control mechanisms

  • Protein complex assembly and coordination

Understanding these functions would be essential for designing appropriate experiments utilizing an antibody against this protein and interpreting the resulting data.

Antigen Design and Preparation

The development of an effective antibody against SPBC18H10.05 would begin with careful antigen design. Based on standard immunological principles and practices observed with other antibodies , several strategies could be employed:

Antigen TypeDescriptionAdvantagesChallenges
Full-length recombinant proteinComplete SPBC18H10.05 protein expressed in bacterial or insect cell systemsContains all potential epitopes; represents the complete proteinComplex expression and purification; potential folding issues
Synthetic peptideShort peptide sequences unique to SPBC18H10.05Easier to synthesize; can target specific regionsMay not represent native conformation; limited epitope options
Domain-specific fragmentsExpressed portions of the protein containing specific functional domainsBalance between specificity and representation of structureRequires precise knowledge of domain boundaries

For SPBC18H10.05, the ideal approach would likely involve targeting unique sequences outside the highly conserved WD repeat domains to ensure specificity to this particular protein rather than cross-reactivity with other WD repeat proteins in the cell.

Production Methodologies

The generation of antibodies against SPBC18H10.05 would follow established immunological protocols, similar to those used for other antibodies like the LDLR Recombinant Monoclonal Antibody described in search result . The process would typically involve:

  1. Immunization of host animals (commonly rabbits, mice, or rats) with the prepared antigen

  2. Collection of serum (for polyclonal antibodies) or isolation of B lymphocytes (for monoclonal antibodies)

  3. For monoclonal antibodies, fusion of B cells with myeloma cells to create hybridomas

  4. Screening and selection of antibody-producing clones with high affinity and specificity

  5. Large-scale production and purification of the antibody

As seen with the His Tag Antibody (clone AD1.1.10) described in search result , successful antibody development requires rigorous selection and validation processes to ensure the final product performs consistently across applications.

Quality Control and Validation

Before an SPBC18H10.05 antibody would be suitable for research applications, it would undergo extensive validation testing:

  • Western blot analysis using S. pombe lysates to confirm specific binding

  • Testing against SPBC18H10.05 knockout or deletion strains as negative controls

  • Cross-reactivity assessment with related WD repeat proteins

  • Application-specific validation for immunofluorescence, immunoprecipitation, and other techniques

  • Batch-to-batch consistency evaluation

These validation steps are critical for ensuring that the antibody produces reliable and reproducible results in experimental settings.

Research Applications for SPBC18H10.05 Antibody

An antibody targeting SPBC18H10.05 would serve as a valuable tool for multiple research applications in S. pombe biology:

Protein Expression Analysis

The SPBC18H10.05 antibody would enable researchers to:

  • Detect and quantify SPBC18H10.05 expression levels via Western blotting

  • Monitor protein synthesis and degradation under different experimental conditions

  • Compare expression between wild-type and mutant strains

  • Assess regulation during different growth phases or stress responses

These applications would be similar to those demonstrated for the His Tag Antibody in detecting His-tagged proteins in HEK293 cell lysates as shown in search result .

Subcellular Localization Studies

Determining the precise localization of SPBC18H10.05 within S. pombe cells would provide valuable insights into its function:

  • Immunofluorescence microscopy to visualize distribution patterns

  • Co-localization studies with organelle markers or potential interacting proteins

  • Tracking changes in localization during cell cycle progression

  • Examining redistribution under various experimental conditions

The immunofluorescence protocols would require optimization for yeast cells, similar to the methanol fixation method mentioned in search result , which describes "Methanol fixation and immunofluorescence labeling" as a technique used in the study of S. pombe proteins.

Protein Interaction Studies

Understanding the interaction partners of SPBC18H10.05 would be crucial for elucidating its cellular functions:

  • Immunoprecipitation to isolate SPBC18H10.05 and associated proteins

  • Co-immunoprecipitation to confirm suspected protein-protein interactions

  • Pull-down assays to characterize protein complexes

  • Chromatin immunoprecipitation if the protein has nuclear functions

These techniques would help place SPBC18H10.05 within the broader context of cellular protein networks and signaling pathways.

Functional Characterization

The antibody could facilitate various functional studies:

  • Tracking post-translational modifications using specific detection methods

  • Monitoring protein levels in response to genetic manipulations

  • Assessing changes in expression or localization during cellular processes like cell division

  • Potential antibody-mediated inhibition studies, if feasible

Yeast-Specific Challenges

Working with antibodies in yeast systems presents unique challenges that would need to be addressed:

  • Cell wall interference: The rigid yeast cell wall can impede antibody penetration, requiring enzymatic digestion methods for immunofluorescence applications

  • Fixation protocols: Specialized fixation methods like methanol fixation (mentioned in search result ) are often needed for optimal epitope preservation in yeast cells

  • Background signal: Yeast cells can exhibit nonspecific binding, necessitating careful blocking and washing procedures

Epitope Accessibility Considerations

WD repeat proteins like SPBC18H10.05 fold into compact structures that may present challenges for antibody binding:

  • Tertiary structure may conceal potential epitopes

  • Protein-protein interactions might mask binding sites

  • Post-translational modifications could alter epitope recognition

Strategies to address these issues would include targeting multiple regions of the protein and using denaturing conditions for some applications.

Control Experiments

Rigorous experimental design would require appropriate controls:

  • SPBC18H10.05 deletion or knockout strains as negative controls

  • Tagged versions of the protein (e.g., epitope tags) as positive controls

  • Peptide competition assays to confirm specificity

  • Secondary antibody-only controls to assess background

Comparative Analysis with Existing Fungal Protein Antibodies

To contextualize the development and application of an SPBC18H10.05 antibody, comparison with antibodies against other fungal proteins is instructive:

Antibody TypeTypical ApplicationsCommon ChallengesOptimization Strategies
Cell wall proteinsSurface labeling, flow cytometryCell wall permeabilityEnzymatic digestion protocols
Cytoskeletal componentsImmunofluorescence, co-IPStructure preservationSpecialized fixation methods
Transcription factorsChIP, nuclear localizationLow abundanceSignal amplification techniques
WD repeat proteins (like SPBC18H10.05)Western blot, IP, IFEpitope accessibilityTarget unique regions, optimize permeabilization

This comparative framework helps place the technical considerations for an SPBC18H10.05 antibody within the broader context of tools used in fungal research.

Future Research Directions

The development of a reliable SPBC18H10.05 antibody would enable several important research directions:

Functional Genomics Studies

  • Systematic analysis of SPBC18H10.05 expression under various environmental conditions

  • Examination of its role in specific cellular pathways

  • Investigation of potential phenotypes associated with altered expression

Comparative Studies Across Species

  • Investigation of functional conservation with homologs in other fungi

  • Comparison with mammalian Wdr44 family proteins

  • Evolutionary analysis of WD repeat protein functions

These studies would contribute to our understanding of fundamental cellular processes in eukaryotes, potentially with broader implications for human cell biology and disease, similar to the insights gained from fission yeast research described in search result .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPBC18H10.05 antibody; Uncharacterized WD repeat-containing protein C18H10.05 antibody
Target Names
SPBC18H10.05
Uniprot No.

Target Background

Database Links
Subcellular Location
Cytoplasm. Nucleus. Note=Localizes at the cell tip and the barrier septum.

Q&A

How should I validate the specificity of an antibody against SPBC18H10.05?

Proper validation is critical before experimental use, as antibody performance varies significantly across applications. A multi-step validation approach should include:

  • Western blot analysis comparing wild-type S. pombe with a SPBC18H10.05 deletion strain

  • Immunoprecipitation followed by mass spectrometry to confirm the pulled-down protein

  • Testing cross-reactivity with recombinant SPBC18H10.05 protein

  • Epitope-tagging the endogenous protein and comparing antibody detection with tag-specific antibodies

This approach follows established validation protocols observed in multiple studies. For example, researchers studying Shb protein employed two positive controls: "The first one corresponds to an over-expression system resulting from HEK 293T cells transiently transfected with a cytomegalovirus (CMV) promoter-driven Stag-Shb-V5 construct. The second one corresponds to an endogenous expression situation where the HEK 293T-derived CE12 cell line has one of its Shb alleles V5-tagged" . Similar methodology should be applied to SPBC18H10.05 antibody validation.

What epitope selection considerations are important for SPBC18H10.05 antibody development?

When developing or selecting antibodies against S. pombe proteins like SPBC18H10.05, epitope selection significantly impacts specificity and functionality:

  • Target unique regions that lack homology with other S. pombe proteins

  • For polyclonal antibodies, N-terminal or C-terminal regions often make good targets

  • Avoid transmembrane regions or highly conserved functional domains

  • Consider protein modifications that might affect epitope accessibility

  • For better immunogenicity, conjugate peptides to carrier proteins like keyhole limpet hemocyanin (KLH)

Commercial antibodies typically adopt these approaches, as seen with other proteins: "Anti-Shb: ab175553 - C-terminal amino acids (67-95) of mouse Shb conjugated to keyhole limpet haemocynin (KLH)" .

What are the recommended applications for SPBC18H10.05 antibodies in S. pombe research?

SPBC18H10.05 antibodies can be utilized in various experimental contexts, but researchers should note that a single antibody may not perform equally well across all applications:

  • Western blotting for protein expression analysis

  • Immunoprecipitation for protein interaction studies

  • Chromatin immunoprecipitation (ChIP) if the protein has DNA-binding properties

  • Immunofluorescence microscopy for subcellular localization

  • Flow cytometry for quantitative analysis

As observed in antibody validation studies: "Several of the antibodies showed shortcomings or were not acceptable for detection of the endogenous protein. The few that could detect Shb were doing so in either western blotting or immunoprecipitation experiments but a given antibody could not work in both applications" . Therefore, validate each antibody specifically for your intended application.

What are the optimal conditions for immunoprecipitation experiments using SPBC18H10.05 antibodies?

For successful co-IP experiments with SPBC18H10.05 antibodies in S. pombe:

  • Cell lysis: Test NP-40 (0.5-1%), RIPA, or milder detergents like digitonin

  • Salt concentration: Start with 150mM NaCl, then adjust based on interaction strength

  • Antibody amounts: Typically 2-5μg per 500μg of protein lysate

  • Pre-clearing: Use protein A/G beads to remove non-specific binders

  • Washing stringency: Balance between maintaining interactions and reducing background

  • Controls: Include IgG control and when possible, a SPBC18H10.05 deletion strain

Effective approaches for S. pombe proteins include: "epitope-tagged each protein at the endogenous locus, affinity purified it from cell lysates, and identified co-precipitating proteins by liquid chromatography - tandem mass spectrometry" .

How can SPBC18H10.05 antibodies be used to study protein complex formation?

For comprehensive identification of SPBC18H10.05-interacting partners:

  • Buffer optimization: Test various ionic strengths and detergent concentrations

  • Cross-linking approaches: Consider formaldehyde or DSP cross-linking to capture transient interactions

  • Mass spectrometry analysis: Use both label-free and isotope-labeled approaches for quantitative assessment

  • Validation: Confirm key interactions by reciprocal IP or proximity ligation assays

This approach has proven successful in studying fission yeast protein complexes: "Saf5 was found to specifically associate with components of the splicing machinery, most notably, all components of the core snRNP including Smd3" .

How can ChIP protocols be optimized using SPBC18H10.05 antibodies for chromatin studies?

Chromatin immunoprecipitation with SPBC18H10.05 antibodies requires specific optimization for fission yeast:

  • Cell fixation: Use 1% formaldehyde for 15-30 minutes at room temperature

  • Cell lysis: Optimize mechanical disruption with glass beads for S. pombe's tough cell wall

  • Sonication: Adjust conditions to achieve chromatin fragments of 200-500bp

  • Antibody concentration: Titrate to determine optimal amount (typically 2-5μg per ChIP reaction)

  • Controls: Include IgG control, input samples, and a strain with deleted or tagged SPBC18H10.05

For validation of ChIP results, consider orthogonal approaches as used in centromeric studies, where researchers measured "centromeric siRNAs in all the mutants, indicative of defective RNAi-mediated processing of non-coding centromeric transcripts" .

How can conflicting results between different SPBC18H10.05 antibody lots be reconciled?

When facing inconsistent results between antibody lots:

  • Epitope mapping: Determine if different lots recognize distinct epitopes

  • Validation series: Re-validate each lot using knockout/knockdown controls

  • Sensitivity testing: Compare detection limits using dilution series of recombinant protein

  • Cross-reactivity assessment: Test against related proteins or in knockout systems

Researchers have noted significant variability: "The few that could detect Shb were doing so in either western blotting or immunoprecipitation experiments but a given antibody could not work in both applications" . This highlights the importance of comprehensive validation for each experimental application.

What are the recommended protocols for generating and validating knockout controls?

For creating effective knockout controls in S. pombe:

  • CRISPR-Cas9 approach: Design guide RNAs targeting early exons of SPBC18H10.05

  • Homologous recombination: Use antibiotic resistance cassettes flanked by homology regions

  • Verification methods: Combine PCR genotyping, sequencing, RT-qPCR, and western blotting

  • Phenotypic characterization: Assess growth, morphology, and related pathway functions

Systematic gene deletion approaches have been successfully employed in fission yeast studies to create comprehensive mutant collections: "we obtained a comprehensive catalog of autophagy genes in this highly tractable organism, including genes encoding three heretofore unidentified core Atg proteins" .

Antibody Specifications and Applications Table

ApplicationRecommended DilutionIncubation ConditionsDetection MethodNotes
Western Blotting1:500-1:2000Overnight at 4°CHRP-conjugated secondary antibody (1:5000)May require optimization based on protein expression level
Immunoprecipitation2-5 μg per 500 μg lysateOvernight at 4°CProtein A/G beadsBuffer composition significantly affects results
ChIP2-5 μg per reactionOvernight at 4°CqPCR or sequencingRequires thorough validation in S. pombe
Immunofluorescence1:100-1:500Overnight at 4°CFluorescent secondary (1:500)Cell wall digestion critical for antibody penetration
ELISA1:1000-1:50001-2 hours at RTHRP-conjugated secondary (1:5000)Follow protocol similar to "Southern Biotech's optimized ELISA procedures"

What approaches can be used to study post-translational modifications of SPBC18H10.05?

To investigate PTMs of SPBC18H10.05:

  • Modification-specific antibodies: Consider developing phospho-, acetyl-, or ubiquitin-specific antibodies

  • Enrichment strategies: Use phosphatase inhibitors, deacetylase inhibitors during sample preparation

  • Sequential immunoprecipitation: First IP with SPBC18H10.05 antibody, then probe with modification-specific antibodies

  • Mass spectrometry validation: Use IP followed by MS to map modification sites

These approaches are particularly important for studying proteins involved in signaling pathways, as demonstrated in studies of platform proteins "involved in receptor tyrosine kinase signalling" .

How can SPBC18H10.05 antibodies be used to investigate protein dynamics during the cell cycle?

For cell-cycle dependent studies in S. pombe:

  • Synchronization methods: Optimize nitrogen starvation/release for S. pombe

  • Time-course sampling: Collect samples at regular intervals following synchronization

  • Fixation protocols: Optimize to preserve cell cycle stage and protein localization

  • Quantitative imaging: Use fluorescence intensity measurements for relative protein levels

  • Co-localization studies: Combine with established cell cycle markers

Similar approaches have been used effectively to study protein dynamics in fission yeast, allowing researchers to "systematically examined the subcellular localization of fission yeast autophagy factors" .

What are the considerations for using SPBC18H10.05 antibodies in multi-protein complex studies?

When investigating complex assemblies:

  • Buffer optimization: Test various ionic strengths and detergent concentrations

  • Sequential immunoprecipitation: Consider tandem IP to isolate specific subcomplexes

  • Density gradient fractionation: Combine with antibody detection to identify complex size

  • Cross-linking strategies: Use graduated cross-linking to preserve interactions

As demonstrated in fission yeast studies: "Saf5 was found to specifically associate with components of the splicing machinery, most notably, all components of the core snRNP including Smd3" , revealing how proper immunoprecipitation conditions can uncover complex protein assemblies.

How can SPBC18H10.05 antibodies be effectively used in chromatin fractionation experiments?

For chromatin association studies in fission yeast:

  • Fractionation protocols: Optimize cytoplasmic, nucleoplasmic, and chromatin fraction separation

  • Salt extraction series: Use increasing NaCl concentrations (100mM to 500mM) to determine binding strength

  • Nuclease treatment: Apply DNase or RNase to distinguish DNA vs. RNA-mediated associations

  • Controls: Include histone antibodies (chromatin), tubulin (cytoplasmic), and nuclear markers

These approaches have been valuable in characterizing novel factors in fission yeast. For instance, researchers identified that "Ctl1 interacts with Atg9 and is required for autophagosome formation" using similar biochemical fractionation approaches.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.